FI915623A - 2b,19-etylenbryggsteroider som aromatasinhibitorer. - Google Patents

2b,19-etylenbryggsteroider som aromatasinhibitorer. Download PDF

Info

Publication number
FI915623A
FI915623A FI915623A FI915623A FI915623A FI 915623 A FI915623 A FI 915623A FI 915623 A FI915623 A FI 915623A FI 915623 A FI915623 A FI 915623A FI 915623 A FI915623 A FI 915623A
Authority
FI
Finland
Prior art keywords
etylenbryggsteroider
aromatasin
som
inhibitor
compounds
Prior art date
Application number
FI915623A
Other languages
English (en)
Other versions
FI915623A0 (fi
FI102073B1 (fi
FI102073B (fi
Inventor
John O'neal Johnston
Norton Paul Peet
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI915623A0 publication Critical patent/FI915623A0/fi
Publication of FI915623A publication Critical patent/FI915623A/fi
Application granted granted Critical
Publication of FI102073B1 publication Critical patent/FI102073B1/fi
Publication of FI102073B publication Critical patent/FI102073B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
FI915623A 1990-11-30 1991-11-28 Menetelmä 2 ,19-etyleenisillan sisältävien, aromataasi-inhibiittoreina käyttökelpoisten steroidien valmistamiseksi FI102073B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62118490 1990-11-30
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (4)

Publication Number Publication Date
FI915623A0 FI915623A0 (fi) 1991-11-28
FI915623A true FI915623A (fi) 1992-05-31
FI102073B1 FI102073B1 (fi) 1998-10-15
FI102073B FI102073B (fi) 1998-10-15

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915623A FI102073B (fi) 1990-11-30 1991-11-28 Menetelmä 2 ,19-etyleenisillan sisältävien, aromataasi-inhibiittoreina käyttökelpoisten steroidien valmistamiseksi

Country Status (20)

Country Link
US (1) US5166201A (fi)
EP (1) EP0488383B1 (fi)
JP (1) JP3143876B2 (fi)
KR (1) KR100190776B1 (fi)
CN (1) CN1033975C (fi)
AT (1) ATE142639T1 (fi)
AU (1) AU635444B2 (fi)
CA (1) CA2056638C (fi)
DE (1) DE69122048T2 (fi)
DK (1) DK0488383T3 (fi)
ES (1) ES2094183T3 (fi)
FI (1) FI102073B (fi)
GR (1) GR3021981T3 (fi)
HU (1) HU210830B (fi)
IE (1) IE914168A1 (fi)
IL (1) IL100196A (fi)
NO (1) NO180304C (fi)
NZ (1) NZ240738A (fi)
PT (1) PT99661B (fi)
ZA (1) ZA919296B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
CN1033975C (zh) 1997-02-05
FI915623A0 (fi) 1991-11-28
AU635444B2 (en) 1993-03-18
DK0488383T3 (da) 1996-09-30
FI102073B1 (fi) 1998-10-15
NO180304B (no) 1996-12-16
CA2056638A1 (en) 1992-05-31
ZA919296B (en) 1992-08-26
NO914710D0 (no) 1991-11-29
FI102073B (fi) 1998-10-15
PT99661B (pt) 1999-05-31
JP3143876B2 (ja) 2001-03-07
US5166201A (en) 1992-11-24
EP0488383A1 (en) 1992-06-03
ATE142639T1 (de) 1996-09-15
HU913739D0 (en) 1992-02-28
HU210830B (en) 1995-08-28
NO914710L (no) 1992-06-01
IL100196A0 (en) 1992-08-18
DE69122048T2 (de) 1997-02-20
KR920009842A (ko) 1992-06-25
IL100196A (en) 1996-03-31
NZ240738A (en) 1993-11-25
KR100190776B1 (ko) 1999-06-01
HUT59937A (en) 1992-07-28
ES2094183T3 (es) 1997-01-16
PT99661A (pt) 1992-10-30
IE914168A1 (en) 1992-06-03
CA2056638C (en) 2002-03-05
GR3021981T3 (en) 1997-03-31
CN1061974A (zh) 1992-06-17
DE69122048D1 (de) 1996-10-17
AU8812891A (en) 1992-06-04
NO180304C (no) 1997-04-02
EP0488383B1 (en) 1996-09-11
JPH04290898A (ja) 1992-10-15

Similar Documents

Publication Publication Date Title
IT1283588B1 (it) Miscela sinergica di agenti stabilizzanti
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
AU9125191A (en) Retroviral protease inhibitors
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
MX9800680A (es) Composicion fungicida sinergistica que incluye un compuesto analogo de estrobilurina.
FI915623A (fi) 2b,19-etylenbryggsteroider som aromatasinhibitorer.
DK1051177T3 (da) Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase
SE7906638L (sv) Peptidderivat
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
BR9713951A (pt) Processo para preparação de 3-hidroxipirazóis n-substituìdos.
BR9914342A (pt) Pirrolidinona, tiazolidinona ou oxazolidinona substituìdos como herbicidas
FI932446A0 (fi) 2b,19-metylaminobrosteroider som aromatasinhibitorer
ES2168062B1 (es) Composiciones para control de cucarachas
FI911529A0 (fi) Halogenetylsubstituerade steroidenzyminhibitorer.
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors

Legal Events

Date Code Title Description
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.